CXCR4 and neoplasm: Some studies have shown that Rh-endostatin can reduce the increased CXCR4 expression involved in the recruitment of Tumor-associated macrophage due to radiotherapy, promote the normalization of tumor blood vessels, and thus enhance the radiotherapy effect (54).